UnitedHealth Group Inc (NYSE:UNH) Director Richard T. Burke sold 6,090 shares of the business’s stock in a transaction on Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the transaction, the director now directly owns 1,711,584 shares in the company, valued at $482,187,444.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of UnitedHealth Group stock traded up $1.60 during trading on Thursday, hitting $282.55. 4,177,054 shares of the stock were exchanged, compared to its average volume of 3,172,149. The firm has a market capitalization of $260.86 billion, a P/E ratio of 28.06, a P/E/G ratio of 1.56 and a beta of 0.78. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69. UnitedHealth Group Inc has a 12 month low of $208.48 and a 12 month high of $285.45.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, topping the consensus estimate of $3.30 by $0.11. The business had revenue of $56.56 billion during the quarter, compared to analyst estimates of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The company’s quarterly revenue was up 12.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.66 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Inc will post 12.8 earnings per share for the current year.
A number of research analysts have recently commented on the stock. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday. Oppenheimer boosted their target price on shares of UnitedHealth Group from $295.00 to $300.00 and gave the stock an “outperform” rating in a research report on Wednesday. Raymond James set a $310.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Wednesday. Bank of America boosted their target price on shares of UnitedHealth Group from $315.00 to $320.00 and gave the stock a “buy” rating in a research report on Wednesday, October 17th. Finally, Piper Jaffray Companies upped their price target on shares of UnitedHealth Group to $312.00 and gave the company an “overweight” rating in a report on Wednesday. Two analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $290.32.
A number of institutional investors and hedge funds have recently made changes to their positions in UNH. White Lighthouse Investment Management Inc. purchased a new stake in UnitedHealth Group during the second quarter valued at about $324,000. Wells Fargo & Company MN grew its stake in shares of UnitedHealth Group by 0.5% in the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after acquiring an additional 39,480 shares during the last quarter. Sawtooth Solutions LLC grew its stake in shares of UnitedHealth Group by 34.4% in the third quarter. Sawtooth Solutions LLC now owns 4,413 shares of the healthcare conglomerate’s stock worth $1,174,000 after acquiring an additional 1,129 shares during the last quarter. HL Financial Services LLC lifted its position in UnitedHealth Group by 15.3% in the third quarter. HL Financial Services LLC now owns 17,183 shares of the healthcare conglomerate’s stock worth $4,572,000 after purchasing an additional 2,281 shares during the period. Finally, Page Arthur B bought a new position in shares of UnitedHealth Group during the third quarter valued at $1,026,000. Hedge funds and other institutional investors own 85.45% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was published by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.themarketsdaily.com/2018/11/30/unitedhealth-group-inc-unh-director-richard-t-burke-sells-6090-shares.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Asset Allocation and Your Retirement
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.